Newton et al., 1993 - Google Patents
Isolation and characterization of flagella from Edwardsiella ictaluriNewton et al., 1993
- Document ID
- 6291648635952937506
- Author
- Newton J
- Triche P
- Publication year
- Publication venue
- Journal of aquatic animal health
External Links
Snippet
Flagella were isolated and purified by acid dissociation and by cell solubilization from 10 isolates of Edwardsiella ictaluri derived from channel catfish Ictalurus punctatus. The preparations were examined ultrastructurally and electrophoretically. Ultrastructurally …
- 210000003495 Flagella 0 title abstract description 67
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0291—Yersinia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from micro-organisms
- Y10S530/825—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wright et al. | The extracellular cytolysin of Vibrio vulnificus: inactivation and relationship to virulence in mice | |
Jacobs et al. | Identification, purification, and characterization of a thiol-activated hemolysin (suilysin) of Streptococcus suis | |
KR100361562B1 (en) | Proteinase K resistant surface protein of Neisseria meningitidis | |
RU2181378C2 (en) | Method of high-level expression, method of purification and method of over-stacking of porine protein of meningococcus of group b external membrane or protein fused with its, highly purified porine protein (variants), highly purified fused protein (variants), vaccine for prophylaxis of bacterial meningitidis of group b, method of preparing conjugate of meningococcus of group b protein and polysaccharide, method of prophylaxis of bacterial meningitidis, strain of escherichia coli (variants) | |
Frasch et al. | Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model. | |
Inzana | Virulence properties of Actinobacillus pleuropneumoniae | |
Bahrani et al. | Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection | |
Genco et al. | Influence of immunization on Porphyromonas gingivalis colonization and invasion in the mouse chamber model | |
Busque et al. | Immunization of pigs against Streptococcus suis serotype 2 infection using a live avirulent strain. | |
PT832093E (en) | Expression of lipoproteins | |
Rioux et al. | Isolation and characterization of a capsule-deficient mutant of Actinobacillus pleuropneumoniae serotype 1 | |
Confer et al. | Recombinant Mannheimia haemolytica serotype 1 outer membrane protein PlpE enhances commercial M. haemolytica vaccine-induced resistance against serotype 6 challenge | |
Deslauriers et al. | SDS‐PAGE analysis of protein and lipopolysaccharide of extracellular vesicules and Sarkosyl‐insoluble membranes from Bacteroides gingivalis | |
NZ263275A (en) | Rib protein from streptococcus, dna encoding it, vectors and compositions | |
JP3236610B2 (en) | Swine pleural pneumonia vaccine | |
JPH03143388A (en) | Vaccine against septicemic bacteria, method of producing antigen of said bacteria, antigen thus produced and novel bacteria and vector for use in producing vaccine | |
Anwar et al. | Antibody response to acute Pseudomonas aeruginosa infection in a burn wound | |
Chamberlain et al. | Neisseria gonorrhoeae strain MS11 harbouring a mutation in gene aroA is attenuated and immunogenic | |
Newton et al. | Isolation and characterization of flagella from Edwardsiella ictaluri | |
Donachie et al. | Sheep antibody response to cell wall antigens expressed in vivo by Pasteurella haemolytica serotype A2 | |
Tamura et al. | Demonstration of protective antigen carried by flagella of Clostridium chauvoei | |
Sherman et al. | Characterization of flagella purified from enterohemorrhagic, vero-cytotoxin-producing Escherichia coli serotype O157: H7 | |
Cho-Rok et al. | Immunization with major outer membrane protein of Vibrio vulnificus elicits protective antibodies in a murine model | |
Singh et al. | Molecular heterogeneity of plpE gene in Indian isolates of Pasteurella multocida and expression of recombinant PlpE in vaccine strain of P. multocida serotype B: 2 | |
WO1993010815A1 (en) | Non-capsulated mutants of bacteria useful as vaccines |